MENUNews Archive
Date: 09/16/2021
President Joseph Biden named Christopher Friese, Ph.D., R.N., among seven new members of the National Cancer Advisory Board, an elite group of 18 cancer clinicians and researchers who play an important role in guiding the director of the National Cancer Institute in setting the course for the national cancer research program. Friese’s term will last six years.
Date: 09/14/2021
Researchers with the SWOG Cancer Research Network have found that patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in their blood serum at the start of anti-estrogen treatment live longer and go longer without their disease progressing than patients with high levels.
Date: 08/27/2021
Communication between patients and their primary care providers is key to ensuring effective cancer care, both before diagnosis and after treatment, according to two recent papers led by University of Michigan Rogel Cancer Center researchers.
Date: 08/13/2021
A simple, wearable temperature sensor was able to detect dangerous complications in hospitalized cancer patients hours earlier than routine monitoring, a team from the University of Michigan Rogel Cancer Center found.
Date: 08/10/2021
A new study led by the University of Michigan Rogel Cancer Center demonstrates how inhibiting a key enzyme known as GOT1 can flip a switch in the cancer cells — causing them to shift from using nutrients to fuel growth toward conserving them to maintain energy levels.
Date: 08/04/2021
Researchers led by the University of Michigan Rogel Cancer Center started with a simple thread: an inhibitor that showed promise against metastatic castration-resistant prostate cancer cells. This is the most challenging type of prostate cancer – advanced disease that has become resistant to hormone-based treatment.
Date: 07/30/2021
A new, University of Michigan-led study analyzing data from more than 850 patients across the state of Michigan, however, found a commercially available genomic test known as Decipher Biopsy may help identify patients who are at high risk of prostate cancer progression.
Date: 07/27/2021
As the academic medical center of the University of Michigan, Michigan Medicine was also given the U.S. News & World Report Honor Roll distinction.
Date: 07/23/2021
A $2.26 million grant from the National Cancer Institute lets Christine Veenstra, M.D., MSHP, study the barriers to equitable use of targeted therapies among diverse patients and diverse practice settings.
Date: 07/20/2021
Younger cancer survivors — those between ages 18 and 64 — faced fewer financial barriers to health care after the Affordable Care Act was implemented than they did before the landmark law took effect, University of Michigan researchers found.